𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Estrogen receptor status in inflammatory breast carcinoma

✍ Scribed by Harold A. Harvey; Allan Lipton; Bellarmine V. Lawrence; Deborah S. White; Samuel A. Wells; George Blumenschein; David Lee

Publisher
John Wiley and Sons
Year
1982
Tongue
English
Weight
240 KB
Volume
21
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Association of hormone replacement thera
Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma
✍ Wendy Y. Chen; Susan E. Hankinson; Stuart J. Schnitt; Bernard A. Rosner; Michell πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 132 KB πŸ‘ 1 views

## Abstract ## BACKGROUND Observational studies and randomized trials have demonstrated that hormone replacement therapy (HRT) increases the recipient's risk of developing breast carcinoma. Because it is known that some breast malignancies are hormonally responsive and that others are not, it has

ESTROGEN AND PROGESTOGEN CYTOSOL RECEPTO
ESTROGEN AND PROGESTOGEN CYTOSOL RECEPTORS IN HUMAN BREAST CARCINOMA
✍ F. May-Levin; F. Guerinot; G. Contesso; J. C. Delarue; C. Bohuon πŸ“‚ Article πŸ“… 1977 πŸ› John Wiley and Sons 🌐 French βš– 555 KB

## Abstract The authors have studied Estrogen (RE) and Progestin (RP) cytosol receptors in 379 human breast carcinomas: 281 tumors suitable for surgery, 26 pseudo‐inflammatory tumors, 52 metastases and 20 recurrences. They have used an exchange technique with estradiol for RE and a synthetic compou